Logo

Utrecht University to Use GeneGo's MetaDrug in Master's Program

Nov 20, 2007

NEW YORK (GenomeWeb News) - Utrecht University will use GeneGo’s MetaDrug software and database platform in its master’s program for drug innovation, GeneGo said today.
 
MetaDrug is designed to predict human metabolism, toxicity, and biological effects of small-molecule compounds.
 
"Academia pushes the limits of MetaDrug,” said Julie Bryant, GeneGo’s vice president of business development, in a statement, because it “allows us to further adapt it for new areas of medicinal chemistry.”
 
Financial terms of the agreement were not released.

Breaking News
The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.